New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation
about
Major Histocompatibility Complex Class II Dextramers: New Tools for the Detection of antigen-Specific, CD4 T Cells in Basic and Clinical ResearchDiabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics.MHC class II tetramersDiversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and functionFlanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized miceIn situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletionDistinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environmentsReverse vaccinology: developing vaccines in the era of genomicsThe utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infectionHeterogeneity within T Cell Memory: Implications for Transplant ToleranceFunctional disruption of human leukocyte antigen II in human embryonic stem cellNegative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populationsInterrogating the repertoire: broadening the scope of peptide-MHC multimer analysisMonitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.Direct staining with major histocompatibility complex class II dextramers permits detection of antigen-specific, autoreactive CD4 T cells in situRegulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.T cells control the generation of nanomolar-affinity anti-glycan antibodiesBasic and translational applications of engineered MHC class I proteins.Viral-specific adoptive immunotherapy after allo-SCT: the role of multimer-based selection strategies.Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.Survey of the 2009 commercial optical biosensor literature.Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells.The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated SignalingDetermining T-cell specificity to understand and treat disease
P2860
Q26799836-104564A6-2EE5-42D1-84F6-9338718CF914Q33934705-C48CD8FE-979E-493E-BB69-EE8D2D24ECC3Q34193211-384974EA-84DB-4F25-A65C-C051C46A4530Q34258556-93832AB2-1CD2-4401-9B1F-C06A7D86D6DEQ34436547-DCD7234C-1761-4435-B570-B4B2922CE637Q34460478-65CF95C3-AE9F-4995-A967-E99F330D21C0Q34713380-80282DA8-E261-45F8-AE04-1AD9FE9D2F3AQ34984511-CB265407-8A50-480B-B905-A2A5A3A7DBD9Q35019501-99586E76-E51C-4F8B-997E-63B8B95FDBDEQ35229338-CD096F5B-73E5-467A-9425-A2F5F19C7107Q35669113-287E8A9B-5BA2-43FF-9130-EE78578A014DQ35701120-FE0DDB31-2898-4756-9AE6-4D8E56F6AC8EQ35873940-7461C46C-2B39-4480-9336-F53FB92D5131Q35903181-D1388DAE-320E-4CF3-A82B-9FC15CF0DF3CQ35927610-8B1C668C-2B96-40FD-9684-06E5AB1D3803Q36220235-7853AF30-F11B-4661-BE5C-652A97B52CD6Q36435501-609E1FB2-B181-4B51-A987-C1C3A179FB63Q36975877-13493D3D-484F-4EF5-932B-EE365E8D5BD7Q36977064-C3403745-CB58-4447-9028-F4DC3470CBC3Q37054621-7BDF4D99-98E8-4D08-AD5D-953E99DD0384Q37521270-C6242C65-3D2E-4FAB-982B-644948E3B4F6Q37700859-29606029-CC19-4B07-8DB1-28C96E79149AQ37730648-D00C9131-6733-4E68-B346-06E9A0FFA863Q37787436-64B540D0-15E1-4B40-85E2-91EF5F09B58CQ38074019-438A25A5-E292-4D89-A3BF-C3A8C563364FQ40358752-A2503007-771D-4FF8-B4B0-0C98095BD0CAQ45399191-30C635C6-AA4E-4184-9460-456A91068238Q47144801-BE92359A-6874-4618-BBD2-AA8F8437270DQ50139317-8514D7A3-0A95-4CD5-96B2-C43CF231F5E9Q57181777-EC7B72E3-53B0-4AE0-8236-934EF83E2D6CQ57201489-2995A81F-0716-4AE0-A912-FEBC4AAB846B
P2860
New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New design of MHC class II tet ...... ciples of antigen presentation
@ast
New design of MHC class II tet ...... ciples of antigen presentation
@en
type
label
New design of MHC class II tet ...... ciples of antigen presentation
@ast
New design of MHC class II tet ...... ciples of antigen presentation
@en
prefLabel
New design of MHC class II tet ...... ciples of antigen presentation
@ast
New design of MHC class II tet ...... ciples of antigen presentation
@en
P2093
P2860
P50
P356
P1476
New design of MHC class II tet ...... ciples of antigen presentation
@en
P2093
Adam L Corper
John D Altman
John Shires
K Christopher Garcia
Luc Teyton
P2860
P304
P356
10.4049/JIMMUNOL.0902493
P407
P577
2009-12-01T00:00:00Z